![Benjamin Guy Davis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Benjamin Guy Davis
Director/Miembro de la Junta en Sugarox Ltd. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Michael Peagram | M | 81 |
Sugarox Ltd.
![]() Sugarox Ltd. Miscellaneous Commercial ServicesCommercial Services Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR). | - |
Bianca Forte | F | 44 |
Sugarox Ltd.
![]() Sugarox Ltd. Miscellaneous Commercial ServicesCommercial Services Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR). | - |
Cara Ashleigh Griffiths | M | - |
Sugarox Ltd.
![]() Sugarox Ltd. Miscellaneous Commercial ServicesCommercial Services Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR). | - |
Matthew Jeremy Paul | M | 61 |
Sugarox Ltd.
![]() Sugarox Ltd. Miscellaneous Commercial ServicesCommercial Services Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR). | 3 años |
Angela Karp | F | 67 |
Sugarox Ltd.
![]() Sugarox Ltd. Miscellaneous Commercial ServicesCommercial Services Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR). | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Landon Clay | M | 98 |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
Elizabeth Phelps | F | - |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
Mario Polywka | M | 61 |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 7 años |
Gavin David Clark | M | 65 |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 3 años |
Louis Joseph Nisbet | M | - |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
Chris Urch | M | - |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 7 años |
Antony J. Fairbanks | M | - |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 9 años |
James Mallinson | M | 63 |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
David Hughes Scales | M | - |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 3 años |
Phillip Dolamore | M | - |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
Niels Reichardt | M | - |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 2 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Reino Unido | 16 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Benjamin Guy Davis
- Red Personal